| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4165200 | The Journal of Pediatrics | 2013 | 7 Pages |
Abstract
Beractant, calfactant, and poractant alfa demonstrated similar effectiveness in prevention of air leak syndromes, death, and BPD or death in premature infants when adjusted for site. Previously described differences in mortality between surfactants likely do not represent true differences in effectiveness but may relate to site variation in outcomes.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Andrea MD, MPH, Christoph P. MD, MPH, Reese MD, P. Brian MD, MPH, MHS, Julie PhD, MPH, Matthew MD, MPH, Best Pharmaceuticals for Children Act-Pediatric Trials Network Best Pharmaceuticals for Children Act-Pediatric Trials Network,